Floatz logo

Therapeutic Asset Ratings

534 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
nb003 tablets
Cancer
Ningbo Newbay Technology Development Co., LtdP1C (39)
Nelmastobart
Cancer
STCube, Inc.P1C (39)
PCLX 001
Cancer
Pacylex PharmaceuticalsP1C (39)
Serabelisib
Cancer
Faeth TherapeuticsP1C (39)
Shr-A2009
Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.P1C (39)
sph5030
Cancer
Shanghai Pharmaceuticals Holding Co., LtdP1C (39)
tt125-802
Cancer
TOLREMO therapeutics AGP1C (39)
yh002
Cancer
Eucure (Beijing) Biopharma Co., LtdP1C (39)
yy001
Cancer
Shanghai Yuyao Biotech Co., Ltd.P1C (39)
zl-1211
Cancer
Zai Biopharmaceutical (Suzhou) Co., Ltd.P1C (39)
dsp107
Cancer
Kahr MedicalP1/2C (39)
[111in]-fpi-2107
Cancer
AstraZenecaP1C (36)
[177lu]lu-xt117
Cancer
Ruimin WangP1C (36)
177Lu-TLX250
Cancer
Telix Pharmaceuticals (Innovations) Pty LimitedP1C (36)
225ac-fapi-xt
Cancer
Xiaorong SunP1C (36)
[225ac]-fpi-2068
Cancer
AstraZenecaP1C (36)
89Zr-DFO-REGN5054
Cancer
Regeneron PharmaceuticalsP1C (36)
89Zr-S095012
Cancer
Institut de Recherches Internationales ServierP1C (36)
abl103
Cancer
ABL Bio, Inc.P1C (36)
abl503
Cancer
ABL Bio, Inc.P1C (36)
Abm-168
Cancer
ABM Therapeutics CorporationP1C (36)
Acc-1898
Cancer
AccSalus Biosciences, Inc.P1C (36)
Acm-Cpg
Cancer
National Cancer Centre, SingaporeP1C (36)
Adce-T02
Cancer
Adcendo ApSP1C (36)
am-928
Cancer
AcadeMab Biomedical Inc.P1C (36)
Showing 251 to 275 of 534 assets
PreviousPage 11 of 22Next